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Abstract A hallmark of gliomas is the growth and migration
of cells over long distances within the brain and proliferation
within selected niches, indicating that the migrating cells
navigate between complex substrates. We demonstrate in the
present study a differential preference for migration that de-
pends on Rho-associated coil kinase (ROCK) signaling, using
the alternating Bonhoeffer stripe assay. Membrane fractions
from nonmyelinated and myelinated brain areas from female
rats, purified myelin also from female rats, and commercial
extracellular matrix were used as substrates, with each sub-
strate being tested against the others. The human tumor cell
lines exhibited a clear preference for extracellular matrix over
all other substrates and for myelinated over nonmyelinated
tissue. ROCK signaling was different when cells were cul-
tured on either substrate. The ROCK inhibitor Y27632 signif-
icantly attenuated and neutralized the preference for
extracellular matrix and myelin, indicating that ROCK con-
trols the substrate selectivity. The findings of this study pave
the way for navigation-targeted therapeutics.
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Introduction
Glioblastoma multiforme is the most common primary brain
tumor, with an incidence of 3–5 per 100,000 population [1].
The prognosis has only slightly improved recently, with a
current median survival of 14.6 months today [2, 3]. One of
the first hallmarks of glioblastoma is nonresectable diffuse
invasion into healthy brain parenchyma, which leads to re-
currences in virtually every patient even when surgery and
chemo/radiotherapy are applied [2–4]. A second hallmark is
the long-distance migration from the primary tumor, often
along white matter tracts, indicating a high affinity for sub-
strates constituting white matter [4–6]. Given the densely
packed nature of cerebral tissue, it is difficult to distinguish
between the different affinities of tumor cells toward particular
components such as myelin, neuronal tissue, extracellular
matrix (ECM), or capillaries. A migrating glioma cell may
simultaneously encounter gray matter, white matter, and ECM
and exhibit different affinities to these components.
Commonly used in vitro migration models such as the
radial migration assay, wound healing assay, and Boyden
chamber assay use components of the ECM as migration
substrates [7–9]. Despite many achievements in the field of
cell migration using these models, the resulting improved
understanding of glioma migration [4] has had only a minor
impact on therapy. These models have revealed that Rho-
associated coil kinases (ROCKs) 1 and 2 (ROCK1 and
ROCK2, respectively) are important molecules controlling
glioma migration that act downstream of the small GTPase
RhoA and functions by phosphorylating proteins such as
myosin II, focal adhesion kinase, LIM kinase, myosin light
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chain phosphatase, and myosin light chain kinase. These
various ROCK-mediated phosphorylation events organize
the actin–myosin cytoskeleton [9, 10]. ROCKS are impor-
tant regulators of microfilament structure, and they have
been reported to both inhibit and promote cell migration in
different cancer cells and in various migration assays
[10–12]. In a brain slice assay, the inhibition of ROCK by
fasudil immobilize glioma cells in intracranial xenograft
models, preventing glioma progression [13]. Thus, the mi-
gration modes of gliomas vary within the complex brain
environment, with some being ROCK dependent and others
being ROCK independent. Live cell imaging of different
substrates remains a challenge regarding the trade-off be-
tween in vivo complexity and spatiotemporal resolution of
cell migration.
To generate such a true decision-taking situation for cells
facing and crossing the interface between two substrates, we
investigated migration preferences using a modification of
the alternating stripe assay developed in the Bonhoeffer
laboratory for studying axonal guidance (henceforth referred
to as the Bonhoeffer assay) to study glioma cell migration
[14, 15]. This device presents two alternating substrates to
the cultured cells. We used five different substrates that were
tested in pairs in every possible combination.
Materials and Methods
Cell Culture
Human glioblastoma cell lines U87MG, A172, D54MG,
and 86HG39 (all cell lines are kind gifts of V. Senner,
Institute of Neuropathology, Muenster, Germany) were cul-
tured in Dulbecco’s modified Eagle’s minimal essential
medium (DMEM) containing 10 % fetal calf serum,
100 U/mL penicillin, and 100 μg/mL streptomycin sulfate
at 37 °C in an incubator with a 5 % CO2 atmosphere [all cell
culture reagents were purchased from PAA (Linz, Austria)].
Stripe Assay
To create substrates that mimic the CNS environment,
nonmyelinated neuronal membrane fractions were prepared
from rat retina (Rr), myelinated membranes were derived
from rat cortex (Rc), CNS myelin (M) was isolated from the
postnatal rat cortex, and the ECM was a commercially
available Biomatrix (BM). A total of 200 female pubs of
the strain Sprague–Dawley were used for substrate prepara-
tion. The striped carpet comprised nucleopore filter mem-
branes loaded in an alternating fashion with two substrates.
The final stripe assay, consisting of two substrates and
glioma cells, was then kept in an incubator at 37 °C for 24
or 48 h. During this period, the cells proliferated and
migrated over the membrane carpets in the absence of
mechanical barriers between the stripes. After 48 h, the
stripe assays were evaluated to determine the cell prefer-
ences for either substrate. The profile of a stochastic cell
distribution is shown in Fig. 1i, whereas Fig. 1j depicts a
90:10 hypothetical preference for one of the substrates test-
ed (Fig. 1). The role of ROCKs was examined by treating
the cells with the selective ROCK inhibitor Y27632, which
was expected to influence substrate-dependent cell migra-
tion [16].
As stripe components, we chose homogenized rat retina
to represent CNS tissue, which is easy to isolate and free of
myelin, and oligodendrocytes to represent gray matter. For
white matter, we chose embryonic chick retina, which, in
contrast to rat retina, contains myelin (Fig. 1e, f). To reveal
whether purified myelin has effects which differ from those
of homogenized white or gray matter, we also isolated
myelin from perinatal rat brains (Fig. 1e, f). For extracellular
matrix, we chose the commercially available Biomatrix
(Serva). The retinas of perinatal rats (postnatal day 10) and
White Leghorn chicken embryos (embryonic day 10) were
explanted and collected into ice-cold homogenization buffer
(HB) containing a protease inhibitor cocktail (Complete
EDTA free; Roche, Basel, Switzerland) (HB+). The tissue
was homogenized first by titration through a 1,000-μL
pipette tip and then through a G27× 0.75-in. needle. The
cell membranes were separated using sucrose gradient cen-
trifugation; 150 μL of a 5 % (v/v) sucrose solution was
pipetted on top of 350 μL of a 50 % (w/w) sucrose solution
and finalized with 800 μL of tissue homogenate. These
setups were centrifuged at 5,525 rcf for 7 min at 4 °C, and
the white rings between the sucrose layers were collected in
1,000 μL of precooled phosphate-buffered saline (PBS; pH
7.4) containing the protease inhibitor cocktail (henceforth
referred to as PBS+). In a second centrifugation (5,525 rcf
for 7 min at 4 °C), the remaining sucrose was washed out,
excess liquid was removed, and the pellets were
resuspended in 1,000 μL of PBS+ and stored in liquid N2.
Myelin fragments were prepared from white matter tracts
obtained from rat brains at postnatal day 10 as described
above. Biomatrix EHS solution, a compound containing
basement membrane components such as laminin, type IV
collagen, entactin, and heparan sulfate, was also used.
The principle of the stripe assay is to present two alternat-
ing stripes of different substrates with no intervening mechan-
ical barriers. This means that cells can freely choose between
the different surfaces during migration, thereby revealing
differences in affinity, motility, and cell proliferation. The
aforementioned substrates were sucked onto a filter mem-
brane (pore size 0.1 μm; Nucleopore track-etched polycar-
bonate membrane, Whatman, Maidstone, UK) via vacuum in
a two-step process. The first set of stripes was prepared by
sucking the suspension through a striped silicone matrix
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containing 90-μm-wide microchannels, upon which the filter
membrane was mounted. The first stripes were formed in the
area above the channels, while the intermediate spaces
remained free. The second set of stripes was then prepared by
changing the striped silicone matrix to a nylon grid, through
which the suspension could pass unhindered. By then
reapplying the vacuum, the second type of substrate settled
within the unoccupied spaces between the first stripes, forming
the second stripes. The filter membranes were rinsed in PBS,
transferred to Petri dishes, and stored in PBS. Our stripe assay
is a modification of the original assay of Bonhoeffer.
After trypsinization and counting the glioma cells, cell
suspension containing cells at a density of 8×104 cells/mL
in DMEM (containing 10 % fetal calf serum, 100 U/mL
penicillin, and 100 μg/mL streptomycin sulfate) was pre-
pared, and 750 μL (=6×104 cells) of the suspension was
added to the stripes. After the cells adhered to the mem-
brane, they were allowed to migrate for either 24 or 48 h,
after which the stripe assay cultures were fixed in 4 %
paraformaldehyde and evaluated by means of immunocyto-
chemistry. The effects of ROCK inhibition were examined
by treating cells growing on either stripe with the ROCK
inhibitor Y27632 (Sigma-Aldrich, St. Louis, MI, USA).
Y27632 was dissolved in H2O to make a stock 3 mM
solution. Y27632 has a half-life of 12–16 h [16], and thus
25 μL of the stock solution was added to the stripe assay
cultures every 12 h to achieve an active final concentration
of 100 μM, which has been shown to be the most effective
concentration over 48 h. To distinguish between the two
stripes being tested, one of them (usually the first) was
labeled by immunocytochemistry. The glioma cells were
also disclosed by immunostaining.
Immunocytochemistry
Immunocytochemistry was performed as follows: the assays
were incubated with fetal calf serum (FCS) containing
0.25 % Triton X-1000 for 2 h to prevent nonspecific anti-
body binding. After washing with PBS once, the first anti-
body (diluted in 10 % FCS) was added and incubated
overnight at 4 °C. The assays were washed twice with
PBS for 20 min each, and then the second antibody (also
diluted in 10 % FCS) was applied and incubated overnight
at 4 °C. The assays were then rinsed three times in PBS,
Fig. 1 Schematic diagrams showing the experimental setup for creating
alternating membrane stripes from different tissues and coculturing with
U87MG cells. a Rat; b chick; c extracellular matrix (Biomatrix); d
purified myelin from rat cortex; e immunoblot to test the content of
myelin using CNPase in different substrates (rat retina, rat brain, chicken
retina, and purified myelin) used for the stipe assay; f corresponding
housekeeping control calnexin; g stripe assay setup with cells; h coculture
of stripe assay with cells; i depiction of a stochastic preference in migra-
tion with a 50:50 distribution; j depiction of a 90:10 preferential distribu-
tion of cells
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transferred onto glass slides, and cover slipped with Mowiol
(Hoechst, Frankfurt am Main, Germany) containing 4′,6-
diamidino-2-phenylindole (Sigma-Aldrich) for nuclear staining.
The following antibodies were used to stain the stripes or
glioma cells:
1. Biomatrix: anti-laminin IgG antibody developed in
mouse (Sigma-Aldrich).
2. Rat retina: anti-rhodopsin IgG antibody developed in
mouse (Millipore).
3. Chick retina: Anti-MOSP IgM antibody developed in
mouse (Chemicon).
4. Myelin: anti-glial fibrillary acidic protein IgG antibody
developed in mouse (Sigma-Aldrich).
5. Glioma cells: anti-vimentin IgG antibody developed in
goat (Millipore).
The following secondary antibodies were used:
1. Tetramethyl-rhodamine isothiocyanate-conjugated anti-
goat IgG antibody developed in donkey (Sigma-
Aldrich).
2. Cy2-conjugated anti-mouse IgG antibody developed in
goat (Jackson Immuno Research Laboratories, Suffolk,
UK).
3. Fluorescein isothiocyanate-conjugated anti-mouse IgM
antibody developed in goat (Jackson Immuno Research
Laboratories).
Immunofluorescence was visualized using a fluorescence
microscope (Axiophot, Zeiss, Oberkochen, Germany) at-
tached to a CCD camera (Zeiss) and was documented dig-
itally (AxioVision, Zeiss).
Immunoblotting
Immunoblotting was performed as described previously
[16]. Briefly, membranes were blocked using 5 % skimmed
milk powder for 30 min and then incubated with a primary
rabbit anti-ROCK1 antibody (diluted to 1:1,000; Sigma-
Aldrich) or with a mouse anti-myelin CNPase antibody
(diluted 1:1,000; Covance) overnight at 4 °C. Protein sig-
naling was detected using a peroxidase-conjugated second-
ary anti-rabbit antibody (NA9340, Amersham) or a
peroxidase-conjugated secondary anti-mouse antibody
(A3682, Sigma) and Amersham electrochemiluminescence
western blotting detection reagents (GE Healthcare). The
membranes were reprobed with an antibody raised against
calnexin (diluted to 1:2,000; Sigma-Aldrich) as a control for
the amount of protein loaded.
Analysis and Statistics
For cell preference analysis, images were blinded for stripe
composition and evaluated by two investigators. There was
no interobserver variability in the evaluation of the experi-
ments. The percentages of cells on the different stripes were
calculated. Statistical analysis was performed with SPSS 14
software (IBM). Results are presented as mean percentage
values, and error bars represent SEM values. Statistical
significance was analyzed using the paired Student’s t test,
and asterisks indicate the representative level of probability
(i.e., *p<0.05; **p=0.001; ***p<0.001).
Atomic Force Microscopy
Atomic force microscopy (AFM) was performed on an
Autoprobe CP atomic force microscope from Park
Scientific Instruments equipped with a laser beam bounce
detection system and a piezo tube sample scanner for the
movements in the lateral and vertical directions. The AFM
measurements were conducted in the operation mode of
amplitude-modulated intermittent contact under ambient
conditions in air. The working procedure for AFM measure-
ments was to image a certain surface area (80×80 μm) of
the stripes and to shift the scan area with respect to the
subsequent image by about 70 μm to ensure complete
coverage of a larger investigation area. A marker was at-
tached mechanically to the sample surface structure to allow
the investigated areas to be identified in the subsequent
fluorescence microscopy.
Quantitative Real-Time PCR
Quantitative RT-PCR was performed by isolating RNA from
human glioma cell lines using the GenElute Mammalian Total
RNA Miniprep kit (Sigma-Aldrich), reverse transcription of
total RNA using a High-Capacity cDNA reverse transcription
kit (Applied Biosystems), and amplifying cDNA on a
StepOne Plus sequence detection system (Applied
Biosystems) using the following primers specific for the re-
spective transcripts in duplicates: ROCK1 human (forward,
AAAAATGGACAACCTGCTGC; reverse, GGCAG
GAAAATCCAAATCAT) and ROCK2 human (forward,
CGCTGTCCGAGACCCT; reverse, TTGTTTTTCCTC
AAAGCAGGA). Data were normalized for glyceraldehyde-
3-phosphate dehydrogenase expression using the comparative
threshold cycle (ΔCt) method.
Pathway Analyses
For signaling pathway analyses, human glioblastoma cells
D54MG and 86HG39 were cultured on coated flask for 72 h
in a density of 1×106 cells. Three different coatings were
used: Biomatrix as an example for ECM, myelin from rat
brain as an example for gray matter, and retina from rat as an
example for unmyelinated tissue (white matter).
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After cells grown for 72 h on the different surfaces, cells
were removed and prepared for western blot analysis. Lysis
of cells and tissue, SDS-PAGE, and blotting were done as
described previously [16]. The rabbit anti-ROCK1 antibody
(Sigma-Aldrich, 1:2,000), diluted 1:1,000, rabbit anti-
ROCK2 antibody (Sigma-Aldrich, 1:2,000), anti-RhoA
(Abcam, mouse, 1:500), anti-pLIMK (cell signaling, rabbit,
1:1,000), anti-pMLC, and anti-pCdc42/Rac (cell signaling,
mouse, and rabbit, respectively, 1:1,000) were incubated
overnight at 4 °C. As secondary antibodies, a peroxidase-
conjugated goat anti-rabbit antibody (Sigma A9169) was
used at 1:50,000 dilution, and a goat anti-mouse antibody
(Sigma, A3682), at 1:50.000 dilution and incubated for 1 h
at room temperature. To verify equal protein loading on
each lane, blots were stripped and reprobed for rabbit anti-
Calnexin (Sigma-Aldrich, 1:2,000).
Results
In the first set of experiments, we tested whether the gliomas
exhibi ted a preference between myelinated and
nonmyelinated tissue and cultured the cells on stripes loaded
in an alternating fashion with either rat cortical or retinal
tissue. It appeared that most of the cells preferred to grow on
cortical tissue (at a ratio of about 60:40; Fig. 2a, d). Most of
the cells were aligned along the substrate interface, mostly
preferring to grow on cortical membranes (Fig. 2b). The
preference between cortex- and retina-derived membranes
was significantly reversed when the ROCK inhibitor
Y27632 was added to the cultured assays (to a ratio of about
20:80; Fig. 2c, d). Figure 1d shows the counts of cells
growing on retina/cortex stripes. No reversal was observed
in controls using retina/retina or cortex/cortex stripes, and
the preference remained at about 50:50 (Fig. 2d). Atomic
force microscopy images showed a uniform plateau of the
stripe channels loaded with membranes (Fig. 2e) and a
uniform distribution of cells (Fig. 2f), indicating the absence
of physical irregularities at the stripe interface. Therefore,
the data demonstrate that the preferential distribution of cells
on the stripes is unlikely to have been caused by differences
in membrane altitude.
The cell preferences for myelin, white matter, gray mat-
ter, and ECM in vitro were determined by presenting the
substrates against each other with the stripe assay. The
differences in cell preferences were greatest between stripe
composites of neuronal tissue and ECM. When gray matter
(e.g., Rr) was presented vs BM, 91.6 % (in the Rr vs BM Ø
setup) and 92.6 % (BM vs Rr Ø) of the cells resided with the
BM stripes, respectively (Fig. 3a). With ROCK inhibition,
there was a shift toward retina tissue with 25.7 % (Rr vs BM
Y) and 9.8 % (BM vs Rr) of glioma cells settling on the Rr
stripes, respectively (Fig. 3a). When Rr was presented vs
cortical M (Rr vs M Ø and M vs Rr Ø), significant prefer-
ences for M of 60.9 and 61.6 % were found in both setups,
respectively (Fig. 3b). With ROCK inhibition, the prefer-
ence was neutralized, with preferences of 50.6 and 49.6 %,
respectively (Fig. 3b). Presenting white matter (e.g., Rc) vs
BM produced approximately the same proportions of cells
settling, with 94.6 % (Rc vs BM Ø) and 93.7 % (BM vs Rc
Ø) of cells preferring BM (Fig. 3c).
With ROCK inhibition, significantly more cells adhered
to the retina substrate in both setups (Rc vs BM Y,
74.0:26 %; BM vs RC Y, 87.6:12.4 %; Fig. 3c). When we
presented white matter (i.e., Rc) vs gray matter (i.e., Rr), we
observed a distinct preference for Rc (Rc vs Rr Ø and Rr vs
Rc Ø), but no shift in allocation with ROCK inhibition in
both the Rc vs Rr Y and Rr vs Rc Y setups (Fig. 3d). In
assays in which M was set against BM, the preferences were
87.3 to 12.7 % (M vs BM Ø) and 83.4 to 16.6 % (BM vs M
Ø) in favor of BM; the distributions changed slightly with
the ROCK inhibitor Y27632, with 74.0 and 81.6 % prefer-
ring BM, respectively (Fig. 3e). When the Rc was presented
vs M, there was a significant preference for cortical M in
both setups (Fig. 3f). This preference was not blocked by
addition of the inhibitor (Fig. 3f). The data show that most
U87MG cells preferentially grew on ECM followed by
cortical M and extracerebral nervous tissues such as mye-
linated Rc and nonmyelinated Rr. Some of these preferences
were neutralized by the ROCK inhibitor.
The physical location of the glioma cells on either stripe
was determined at the end of each experiment using selected
antibodies that facilitated recognition of the stripes and cells.
Figure 4 shows representative fluorescence images used to
quantify the data. There was a clear preference of the cells
for M over Rr in the untreated setup. This preference was
partly neutralized in inhibitor-treated setups. When BM was
tested vs M, most of the cells adhered to the BM. This
strong preference was also neutralized when the inhibitor
was added to the stripes (Fig. 4).
To examine whether the results obtained with the human
glioblastoma cell line U87MG also applied to other cell
lines, we cultured three other cell lines (86HG39, D54MG,
and A172 cells) with the stripe assays composed of matrix,
rat M, and nonmyelinated Rr and tested them against each
other. It appeared that all of these cell lines expressed
ROCK1 and ROCK2 mRNA at comparable levels (Fig. 5).
In immunoblots, ROCK1 and ROCK2 were expressed at
protein levels (data not shown). As shown paradigmatically
in Fig. 6a, b for the 86HG39 cell line, the cells clearly
preferred BM over M (Fig. 6a), and this preference was
changed after inhibition of ROCK1 (Fig. 6b). This change
in the substrate preference was shown quantitatively in
stripes testing either M vs BM in three cell lines (Fig. 6c)
or Rr vs BM (Fig. 6d). In the testing of M vs Rr, there was a
preference for retinal membranes over M (Fig. 6e), with the
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addition of the inhibitor further enhancing this preference in all
three cell lines tested (Fig. 6e). These data indicate that the stripe
assay is a suitable and sensitive method for detecting ROCK1-
dependent changes in the preference of glioblastoma cells.
To examine possible changes in intracellular signaling
pathways dependent on cell growth on different substrates
(biomatrix, myelin, and retina), western blotting was used
with the lines DM54MG and 86HG39 which expressed
variable, yet comparable amounts of ROCK1 and ROCK2
(Fig. 7). Expression of RhoA was enhanced in cells on
unmyelinated tissue. P-LIMK1 revealed a different expres-
sion level in both used cell lines. For D54MG, expression of
p-LIMK1 was increased on myelinated surfaces, for
86HG39 on unmyelinated surfaces. P-LIMK2 displayed
also a cell-based expression level with the highest expres-
sion on unmyelinated tissue for D54MG cells and on
Biomatrix for 86HG39 cells. P-MLC showed an increased
expression on unmyelinated tissue in both cell lines.
pCDC42/Rac displayed an elevated protein expression level
in cells grown on unmyelinated tissue compared to
Fig. 2 Example of cell growth
on nonmyelinated rat retina vs
myelinated rat cortex substrate.
a Demonstration of a
membrane with cells preferring
cortex (red) as migration
substrate. b Larger
magnification of a parallel
experiment showing individual
cells that extend growth
processes and prefer cortex
(red) over retina as substrate. c
Addition of Rho kinase
inhibitor Y27632 allows growth
of the cells, but with reversal of
the preference. d Quantitative
analysis showing that the
inhibitor of Rho-associated coil
kinase reverses the preference
of glioma cells for cortex as
migration substrate. Repeating
the setup with retina/retina or
cortex/cortex showed no
preference. e Atomic force
microscopy showing the
surface of a stripe assay with no
detectable difference in height
between the stripes. f Example
of a stripe assay showing
uniform distribution of cells
across the membrane
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Biomatrix coating (Fig. 7). Figure 8 illustrates the cell
signaling pathways on the different substrates.
Cell motility studies were essential for monitoring how
the cells gained their final distribution on the alternate
stripes. Representative sequences of the assays over time
were recorded using time-lapse videomicroscopy. This dem-
onstrated clearly that untreated U87MG cells meandered
around the substrates and selectively preferred to attach
and grow on BM over M (link to video 1 and legend
“untreated” in the link http://www.melkonyan.de/ROCK/
ROCK.php). Inhibition of ROCK with Y27632 attenuated
the cell motility and diminished their selectivity for either
substrate (link to video 2 and legend “treated with ROCK
inhibitor” in the link http://www.melkonyan.de/ROCK/
ROCK.php).
Discussion
It is highly likely that the direction of glioblastoma migra-
tion is not determined by a single mechanism, but rather
occurs via different pathways depending on the microenvi-
ronment that is serving as a substrate. The advantage of the
stripe assay over conventional models used to study cell
Fig. 3 Histograms showing the quantification of U87MG cells grow-
ing on alternating stripes. In all boxes, two setups are shown with a
reversed arrangement of membranes on the stripes. For instance, retina
first and BM second (left) and then BM first and retina second (right)
during the production of stripes to ensure that differences are not
attributable to the stripe production process. a It appeared that BM
without inhibitor (i.e., Rr vs BM Ø and Rr vs BM Ø) attracted most of
the cells when confronted with rat retina, whereas treatment with the
inhibitor was effective (i.e., Rr vs BM Y and BM vs Rr) and signifi-
cantly reduced the preference for BM. b Confronting Rr with purified
rat cortex M revealed a significant preference for M. This preference
was neutralized after treatment with the inhibitor. c–f) Further confron-
tations of substrates showing clear preferences for BM over chick
retina (c), Rc over Rr (d), M over BM (e), and Rc over M (f).
Horizontal bars over each arrangement show the statistical probability
values
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migration is the opportunity to present two alternating sub-
strates and to examine the preference for either of them in a
controlled fashion. The data presented here support the view
that techniques used to unravel the mechanisms of cell
migration within the complex brain environment may in-
volve the selective inhibition of these cells and blockage of
diffuse migration within the tissue. However, more sub-
strates, such as components of the brain vessels or individ-
ual constituents of the ECM, need to be tested. Although
human cell lines were tested, they showed a clear preference
on rat myelin or on rat and chicken retinal membranes. These
data point to cross-reactivity between the species. However,
rat cell line C6 has been recently tested by using chick neuro-
nal fibers—C6 assay—and showed similar properties in rela-
tion to expression of ROCK and cell migration [16].
The high resolution of the stripe assay revealed that
ROCK inhibition resulted in changes in cell preferences,
and especially in a shift away from ECM toward each other
brain substrate. From the therapeutic point of view, these
changes are fundamental in order to understand that glioma
cells may use alternative pathways of migration, likely by
using different cell signaling. In turn, knowledge of these
different signaling pathways may help to better understand
the molecular mechanisms of migration, and thus of design-
ing therapeutic strategies. These findings are especially in-
teresting when combined with the previous finding that
glioblastoma cell migration on ECM is not ROCK depen-
dent [10–12, 17]. The increased cell preference for white
matter, gray matter, and M when presented vs ECM indi-
cates an immobilization of glioblastoma cells due to ROCK
on all the neuronal substrates: white matter, gray matter, and
purified M. When only neuronal substrates (white matter,
gray matter, and M) were used in the ROCK inhibition
assays, there was a trend for cells to be more profoundly
Fig. 4 Fluorescence
photomicrographs showing the
distribution of U87MG cells on
alternating stripes: a Rr vs M
without inhibitor, b Rr vs M
plus ROCK inhibitor, c BM vs
M without inhibitor, and d BM
vs M with inhibitor. Scale bar,
100 μm
Fig. 5 mRNA expression of ROCKs in glioblastomas. a Quantitative
RT-PCR of ROCK1 mRNA in different glioblastoma cell lines reveal-
ing comparable ΔCt values of seven different cell lines. b mRNA
expression of ROCK2 mRNA in different glioblastoma cell lines
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inhibited on white and gray matter than on M, indicating
that ROCK is required more for migration along axonal
structures, whether myelinated or nonmyelinated, than on
purified M. ROCK seems to be a major molecular player
required for the migration of glioblastoma cells along the
tissues of their preferred migration routes in vivo: axons,
myelinated axons, and purified M. As shown recently, cy-
tokine signaling through the receptor GP-130-IL6ST and the
kinase JAK1 also generates contractility of cellular actomy-
osin through ROCK-dependent signaling [12]. It is therefore
not surprising that ROCK inhibition has been shown to
suppress glioblastoma growth in vivo [13, 16].
Fig. 6 Substrate preferences of
different glioblastoma cell lines.
a, b Distributions of 86HG39
cells cultured on the stripe assay
consisting of myelin (M) or
Biomatrix (BM) without (a) and
with (b) the inhibitor. Note that
the inhibitor results in a
substantial redistribution of
cells from BM to M. c–e
Quantification of three cell lines
tested in the stripe assay
without (left histograms, Ø) and
with (right histograms, Y) the
inhibitor
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In summary, the findings of this study demonstrate clear-
ly that glioblastoma migration and substrate preferences
are distinct to the cellular and acellular substrate, which
helps to explain the great complexity of tumor migra-
tion within the brain. In this context, the stripe assay
may be able to reveal the molecular cues of glioblasto-
ma migration on each of the substrates that are used in
vivo, as predicted from its original use. The stripe assay
setup represents a compromise between the complexity of in
vivo models and the high resolution of in vitro models that is
necessary to reveal fundamental cellular processes, and can be
successfully transferred to tumor research. It is likely that the
stripe assay will also be applicable to other tumors throughout
the body.
Fig. 7 Signaling pathway
analyses of glioblastoma cell
lines growing on three different
substrates. a Western blot
analyses of the cell lines
D54MG and 86HG39 growing
on Biomatrix, myelinated
brain tissue, and unmyelinated






analyzed. b, c Densitometric
measurement of western blots
for D54MG cells (b) and
86HG39 cells (c). Cells grown
on BM displayed a higher
expression of ROCK1 and
ROCK2 compared to cells
growing on myelin and
retina. Furthermore expression
of all tested proteins varies
between the three substrates
cells grown on
Fig. 8 Graphs showing the different regulation of glioma cell signal-
ing when cells were cultured on biomatrix, myelin and unmyelinated
tissue (retina). Arrows indicate the up- and downregulation of
intracellular signaling members of the Rho kinase pathway. These
differences likely explain that alternative pathways exist for migration
on different substrates
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